Vik Bajaj has long lived at the intersection of physical sciences, engineering, data science, and the life sciences—first as an academic working to improve diagnostic imaging at Stanford University and later as a chief scientific officer at GRAIL and Verily. Now, as a founder and CEO of Foresite Labs, the technologist turned venture capitalist is using his experience to create new companies that are leveraging AI and other technologies to transform healthcare. We spoke to Bajaj about the changing data landscape around healthcare, the potential for technology to improve health outcomes, and what it takes for an entrepreneur to get his attention today.
A Venture Capitalist’s View of the Current Biotech Landscape
Realizing the Therapeutic Potential of Cytokines by Making them Context Dependent
Targeting Cancer and Autoimmune Conditions with Donor-Derived EBV T Cells
Reprogramming the Tumor Microenviroment to Activate an Immune Response
Making Safer and More Effective Vaccines with Targeted mRNA
Addressing a Global Need with RNA Vaccines and Immunotherapies
Targeting Bacteria in Chronic Diseases
Targeting Solid Tumors with Off-The-Shelf CAR T Therapies
Reimagining the Development of Immunotherapies with a Venture Studio
Repairing the Body with Advanced Cell Therapies
Achieving Precision with AI Pathology
Inducing Potent and Durable T Cell Responses to Fight Disease
Developing Immunotherapies that Target the Drivers of Cancer
Using Phase 0 Trials to Bring Precision Medicine to Treating Brain Tumors
Restoring Feeling and Function to Damaged Nerves
Enlisting Vaccines in the Fight Against Chronic Diseases
Extending the Reach of Protein Degradation Therapies
Growing the Bioeconomy
Developing Targeted Therapies to Address Resistance in Cancer
It Takes a Village
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Short Wave
Stuff To Blow Your Mind
Unexplainable
Speaking of Psychology